UNSPSC 85816022: Introduction of monoclonal antibody into peripheral artery, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into peripheral artery, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0500M

UNSPSC 85816022 Introduction of monoclonal antibody into peripheral artery, open approach is a Commodity code that shows little relevant recent activity — the opportunities tagged under it encompass virtual urgent care services, medical services contracts, nursing home operations, occupational health services, cancer screening, employee wellness platforms, and opioid use disorder treatment, none of which align with the code's clinical procedural scope. The mismatch between the code's nominal focus (a specific vascular intervention using monoclonal antibodies) and the breadth of general healthcare and behavioral health services appearing in recent postings suggests either systematic tagging misalignment or that state and local procurement bodies rarely solicit this specific procedure through competitive processes.

Recent activity under the code spans multiple states and issuing bodies: Inland Empire Health Plan (California) posted an RFI for virtual urgent care on October 16, 2026; DeKalb County, Georgia issued an RFP for general medical services due November 12, 2026; the Nevada Health Authority released two separate RFPs for Program of All Inclusive Care for the Elderly (PACE) operations and a Rural Value Acceleration Network vendor, both due in late 2026 or early 2027; San Mateo County, California solicited cancer registry services and handheld retinal screening devices; and Colorado, Texas, Florida, Kansas, and other states issued health services RFPs across occupational health, emergency medical services staffing, employee clinics, and opioid treatment programs. The issuing bodies include state health departments (Nevada, Texas, Colorado), counties (Santa Clara, San Mateo, DeKalb, Cobb, Forsyth, Ventura), cities (Phoenix, Ocala, Atlanta, Boulder County Sheriff), health systems, and cooperative purchasing vehicles. Geographic spread is nationwide with concentration in California, Colorado, Nevada, Texas, Georgia, and Florida. None of the recent opportunities target the specific monoclonal antibody-peripheral artery procedure named in the code; business development professionals should verify coding accuracy before pursuing activity under this classification.